Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Brady Urology Health Cntr.
Androgen receptor expression inversely correlates with pathologic, tumor stage
November 6th, 2004
Androgjen receptor expression is inversely correlated with pathologic, tumor stage in bladder cancer. Researchers in the United States conducted a study "to evaluate the expression of the androgen receptor (AR) in transitional cell carcinoma (TCC) of the bladder, and to assess whether its expression correlated with pathologic tumor stage. TCC of the bladder is three times more common in males than in females. The origin of this sex difference in incidence is unknown." "We evaluated tumor specimens from 49 consecutive patients treated for TCC of the bladder at our institution between July 2002 and June 2003. Immunohistochemistry was performed using a...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2004-11-06)
|
